NO20044954L - Bazedoxifen behandlingsregimer - Google Patents
Bazedoxifen behandlingsregimerInfo
- Publication number
- NO20044954L NO20044954L NO20044954A NO20044954A NO20044954L NO 20044954 L NO20044954 L NO 20044954L NO 20044954 A NO20044954 A NO 20044954A NO 20044954 A NO20044954 A NO 20044954A NO 20044954 L NO20044954 L NO 20044954L
- Authority
- NO
- Norway
- Prior art keywords
- bazedoxifene
- treatment regimens
- azepan
- indol
- hydroxyphenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Denne oppfinnelse angår utvidede doseringsregimer for den selektive østrogenreseptormodulator bazedoxifen (1 -[4-(2-azepan-1-yl-etoksy)-benzyl]-2-(4-hydroksyfenyl)-3-metyl-1H-indol-5-ol).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38859602P | 2002-06-13 | 2002-06-13 | |
PCT/US2003/019011 WO2003105834A1 (en) | 2002-06-13 | 2003-06-13 | Bazedoxifene treatment regimens |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20044954L true NO20044954L (no) | 2004-12-16 |
Family
ID=29736501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044954A NO20044954L (no) | 2002-06-13 | 2004-11-12 | Bazedoxifen behandlingsregimer |
Country Status (20)
Country | Link |
---|---|
US (1) | US20040063692A1 (no) |
EP (1) | EP1531807A4 (no) |
JP (1) | JP2005531613A (no) |
KR (1) | KR20050010886A (no) |
CN (1) | CN1658868A (no) |
AU (1) | AU2003248707A1 (no) |
BR (1) | BR0311774A (no) |
CA (1) | CA2489098A1 (no) |
CR (1) | CR7585A (no) |
EC (1) | ECSP045492A (no) |
IL (1) | IL165210A0 (no) |
MX (1) | MXPA04011634A (no) |
NI (1) | NI200400065A (no) |
NO (1) | NO20044954L (no) |
NZ (1) | NZ537051A (no) |
RU (1) | RU2355397C2 (no) |
SG (1) | SG162615A1 (no) |
UA (1) | UA85374C2 (no) |
WO (1) | WO2003105834A1 (no) |
ZA (1) | ZA200409991B (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG149081A1 (en) * | 2004-01-13 | 2009-01-29 | Wyeth Corp | Treatment of aromatase inhibitor therapy-related osteoporosis |
AR048534A1 (es) * | 2004-04-08 | 2006-05-03 | Wyeth Corp | Formulaciones de acetato de bazedoxifeno |
MXPA06011686A (es) * | 2004-04-08 | 2006-12-14 | Wyeth Corp | Ascorbato de bazedoxifeno como modulador del receptor de estrogeno selectivo. |
EP1863464B1 (en) * | 2005-03-31 | 2009-11-11 | Wyeth | O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
AR054806A1 (es) * | 2005-06-29 | 2007-07-18 | Wyeth Corp | Formulaciones de estrogenos conjugados y bazedoxifeno |
CA2620174A1 (en) * | 2005-08-24 | 2007-03-01 | Wyeth | Bazedoxifene acetate formulations and manufacturing process thereof |
EP2086550A2 (en) * | 2006-11-29 | 2009-08-12 | Wyeth | Estrogen/ serm and estrogen/ progestin bi-layer tablets |
ITMI20091109A1 (it) | 2009-06-23 | 2010-12-24 | Wyeth Corp | Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione |
WO2013182169A1 (en) * | 2012-06-07 | 2013-12-12 | Zentiva, K. S. | Process of preparation of an antioxidant-free polymorphically and chemically stable formulation of bazedoxifene acetate |
KR101940569B1 (ko) * | 2017-05-24 | 2019-01-21 | 아주대학교산학협력단 | 바제독시펜 또는 이의 약학적으로 허용가능한 염을 포함하는 약학 조성물 |
CN112076163B (zh) * | 2019-06-14 | 2023-06-20 | 四川科伦药物研究院有限公司 | 一种醋酸巴多昔芬片的药物组合物及其制备方法 |
CN113244240A (zh) * | 2021-05-26 | 2021-08-13 | 深圳市人民医院 | 醋酸巴多昔芬在治疗急性髓系白血病药物中的应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW303299B (no) * | 1993-07-22 | 1997-04-21 | Lilly Co Eli | |
US5998402A (en) * | 1996-04-19 | 1999-12-07 | American Home Products Corporation | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
DE69707189T2 (de) * | 1996-04-19 | 2002-06-20 | American Home Prod | Östrogene Verbindungen |
US6583170B1 (en) * | 1998-05-15 | 2003-06-24 | Wyeth | 2-Phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol and estrogen formulations |
US6479535B1 (en) * | 1998-05-15 | 2002-11-12 | Wyeth | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
CA2414111A1 (en) * | 2000-07-06 | 2002-01-17 | Wyeth | Use of substituted indole compounds for increasing nitric oxide synthase activity |
AR029538A1 (es) * | 2000-07-06 | 2003-07-02 | Wyeth Corp | Composiciones farmaceuticas de agentes estrogenicos |
AU2001271784A1 (en) * | 2000-07-06 | 2002-01-21 | Wyeth | Therapy for prosthesis-related bone degeneration |
EP1192945A3 (en) * | 2000-09-21 | 2004-03-03 | Pfizer Products Inc. | Use of an estrogen agonist/antagonist for treating osteoarthritis |
-
2003
- 2003-06-13 NZ NZ537051A patent/NZ537051A/en unknown
- 2003-06-13 RU RU2004136316/14A patent/RU2355397C2/ru not_active IP Right Cessation
- 2003-06-13 SG SG200608134-3A patent/SG162615A1/en unknown
- 2003-06-13 BR BRPI0311774-0A patent/BR0311774A/pt not_active IP Right Cessation
- 2003-06-13 UA UA20041210175A patent/UA85374C2/ru unknown
- 2003-06-13 WO PCT/US2003/019011 patent/WO2003105834A1/en active Search and Examination
- 2003-06-13 US US10/460,843 patent/US20040063692A1/en not_active Abandoned
- 2003-06-13 KR KR10-2004-7020140A patent/KR20050010886A/ko not_active Application Discontinuation
- 2003-06-13 CA CA002489098A patent/CA2489098A1/en not_active Abandoned
- 2003-06-13 CN CN03813425XA patent/CN1658868A/zh active Pending
- 2003-06-13 MX MXPA04011634A patent/MXPA04011634A/es unknown
- 2003-06-13 AU AU2003248707A patent/AU2003248707A1/en not_active Withdrawn
- 2003-06-13 JP JP2004512738A patent/JP2005531613A/ja active Pending
- 2003-06-13 EP EP03760414A patent/EP1531807A4/en not_active Withdrawn
-
2004
- 2004-11-12 NI NI200400065A patent/NI200400065A/es unknown
- 2004-11-12 NO NO20044954A patent/NO20044954L/no not_active Application Discontinuation
- 2004-11-15 IL IL16521004A patent/IL165210A0/xx unknown
- 2004-11-24 CR CR7585A patent/CR7585A/es not_active Application Discontinuation
- 2004-12-09 ZA ZA200409991A patent/ZA200409991B/en unknown
- 2004-12-13 EC EC2004005492A patent/ECSP045492A/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR0311774A (pt) | 2007-05-08 |
UA85374C2 (en) | 2009-01-26 |
EP1531807A4 (en) | 2007-10-31 |
KR20050010886A (ko) | 2005-01-28 |
US20040063692A1 (en) | 2004-04-01 |
NI200400065A (es) | 2005-08-09 |
MXPA04011634A (es) | 2005-07-05 |
RU2355397C2 (ru) | 2009-05-20 |
EP1531807A1 (en) | 2005-05-25 |
ZA200409991B (en) | 2007-09-26 |
IL165210A0 (en) | 2005-12-18 |
NZ537051A (en) | 2007-11-30 |
CA2489098A1 (en) | 2003-12-24 |
CR7585A (es) | 2008-10-03 |
ECSP045492A (es) | 2005-03-10 |
WO2003105834A1 (en) | 2003-12-24 |
RU2004136316A (ru) | 2005-05-10 |
AU2003248707A1 (en) | 2003-12-31 |
CN1658868A (zh) | 2005-08-24 |
JP2005531613A (ja) | 2005-10-20 |
SG162615A1 (en) | 2010-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008003391A1 (es) | Compuestos derivados de pirrolidinas, moduladores de la funcion del receptor de androgeno (divisional de la solicitud 970-03). | |
TR200300322T2 (tr) | Kemokin alıcısını bağlayan heterosiklik bileşikler | |
NO20044954L (no) | Bazedoxifen behandlingsregimer | |
ATE501118T1 (de) | Substituierte indole | |
DK1817295T3 (da) | Triazolforbindelser, der modulerer HSP90-aktivitet | |
NO20051337L (no) | Indol- eller benzimidazolderivater for modulering av ikB-kinase. | |
NO20052198D0 (no) | Enkeltkjedede, rekombinante T-cellereseptorer | |
EA200500520A1 (ru) | Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов | |
ATE402928T1 (de) | Sulphonamidverbindungen, die die chemokinrezeptoraktivität (ccr4) modulieren | |
EA200501430A1 (ru) | Лиганды каннабиноидных рецепторов и их применение | |
DE602005015962D1 (de) | Indolylderivate als liver-x-rezeptormodulatoren | |
ATE388937T1 (de) | Agonisten des cannabinoidrezeptors | |
EA200501504A1 (ru) | Лиганды каннабиноидных рецепторов и их применение | |
DK1505974T3 (da) | Anvendelse af forbindelser, der er effektive som selektive opiatreceptormodulatorer | |
AR048394A1 (es) | Tratamiento de la osteoporosis relacionada con la terapia de inhibidor de aromatasa | |
DK1636221T3 (da) | 3-Heterocyclyl-azetidin-forbindelser, som er nytte som NK1/NK2 receptorantagonister | |
ATE478845T1 (de) | Pyrrolidiniumderivative als liganden für den muscarinen m3-rezeptor | |
NO20034130L (no) | Benzimidazolderivater som modulerer kjemokinreseptor | |
DE60316180D1 (de) | Aminoalkoxyindol-derivate als 5-ht6-rezeptorliganden zur bekämpfung von zns-krankheiten | |
MA25264A1 (fr) | 3-[benz(ox/thi)azol-7-yl)-1h-pyrimidine-2,4-diones | |
ATE273389T1 (de) | Rezeptor des y-y5 neuropeptids | |
ATE495168T1 (de) | Heteroarylsubstituierte imidazolderivate als glutamatrezeptorantagonisten | |
AR047762A1 (es) | Sales y polimorfos de un compuesto de indolinona sustituido con pirrol | |
NO20055493D0 (no) | 8??-vinyl-11??-(w-substituerte)alkyl-ostra-1,3,5(10)-triener | |
ITRM20020141U1 (it) | Pedale per comandi elettrici, primari ed ausiliari. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |